IREDA Appoints Manoneet Dalal as Independent Director

Indian Renewable Energy Development Agency Limited (IREDA) has announced the appointment of Shri Manoneet Dalal as a Non-Official Director (Independent Director) on its board. This appointment, effective August 18, 2026, is for a period of three years. Shri Dalal brings over 20 years of experience in taxation, financial consulting, and public administration, with an LL.M. from NLSIU Bengaluru.

New Independent Director Joins IREDA Board

The Board of Directors of Indian Renewable Energy Development Agency Limited (IREDA) has officially welcomed Shri Manoneet Dalal as a Non-Official Director, designated as an Independent Director. This appointment was conveyed by the Ministry of New and Renewable Energy via an order dated August 18, 2026, and formally ratified by IREDA’s Board through a resolution passed on the same day.

Director’s Profile and Tenure

Shri Manoneet Dalal’s tenure as an Independent Director will span three years, commencing from August 18, 2026, or until further orders, whichever is earlier. He is a seasoned legal and financial professional with more than two decades of extensive experience across taxation, financial consulting, legal advisory, public administration, and technology sectors. Shri Dalal holds an LL.M. from the prestigious National Law School of India University (NLSIU), Bengaluru, and a B.A. LL.B. (Hons.) from Kurukshetra University.

Currently, Shri Dalal serves as a Director at Hexa Advisors Limited, a specialized advisory firm focusing on financial modelling, valuation, and cross-border transaction advisory. His prior professional experience includes senior roles at well-known firms such as Deloitte Haskins & Sells and Ernst & Young. Furthermore, he has made significant contributions to public policy research and has authored several books and research papers on taxation and international trade law. His appointment is expected to bring valuable expertise to IREDA’s strategic direction and governance.

Source: BSE

Previous Article

Natco Pharma: Investor Presentation Highlights FY26 Performance and Growth Strategy

Next Article

Ceigall India: Wins ₹274 Crore Road Construction Contract